Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c) Dobaño, Carlota et al., 2022
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/186809

Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

COVID-19 affects children to a lesser extent than adults but they can still get infected and transmit SARS-CoV-2 to their contacts. Field deployable non-invasive sensitive diagnostic techniques are needed to evaluate the infectivity dynamics of SARS-CoV-2 in pediatric populations and guide public health interventions, particularly if this population is not fully vaccinated. We evaluated the utility of high-throughput Luminex assays to quantify saliva IgM, IgA and IgG antibodies against five SARS-CoV-2 spike (S) and nucleocapsid (N) antigens in a contacts and infectivity longitudinal study in 122 individuals (52 children and 70 adults). We compared saliva versus serum/plasma samples in infected children and adults diagnosed by weekly RT-PCR over 35 days (n=62), and those who consistently tested negative over the same follow up period (n=60), in the Summer of 2020 in Barcelona, Spain. Saliva antibody levels in SARS-CoV-2 RT-PCR positive individuals were significantly higher than in negative individuals and correlated with those measured in sera/plasmas. Asymptomatic infected individuals had higher levels of anti-S IgG than symptomatic individuals, suggesting a protective anti-disease role for antibodies. Higher anti-S IgG and IgM levels in serum/plasma and saliva, respectively, in infected children compared to infected adults could also be related to stronger clinical immunity in them. Among infected children, males had higher levels of saliva IgG to N and RBD than females. Despite overall correlation, individual clustering analysis suggested that responses that may not be detected in blood could be patent in saliva, and vice versa. In conclusion, measurement of SARS-CoV-2-specific saliva antibodies should be considered as a complementary non-invasive assay to serum/plasma to determine COVID-19 prevalence and transmission in pediatric populations before and after vaccination campaigns.

Matèries (anglès)

Citació

Citació

DOBAÑO, Carlota, ALONSO, Selena, VIDAL, Marta, JIMÉNEZ, Alfons, RUBIO, Rocío, SANTANO, Rebeca, BARRIOS, Diana, PONS TOMÀS, Gemma, MELÉ CASAS, Maria, HERNÁNDEZ GARCÍA, María, GIRONA ALARCÓN, Mònica, PUYOL, Laura, BARO, Bàrbara, MILLAT MARTÍNEZ, Pere, AJANOVIC, Sara, BALANZA LOMBARDIA, Núria, ARIAS, Sara, RODRIGO MELERO, Natalia, CAROLIS, Carlo, GARCÍA MIQUEL, Aleix, BONET CARNÉ, Elisenda, CLAVEROL, Joana, CUBELLS, Marta, FORTUNY GUASCH, Claudia, FUMADÓ, Victoria, CODINA, Anna, BASSAT ORELLANA, Quique, MUÑOZ ALMAGRO, Carmen, FERNÁNDEZ DE SEVILLA ESTRACH, Mariona, GRATACÓS SOLSONA, Eduard, IZQUIERDO LÁZARO, Luis, GARCÍA GARCÍA, Juan josé, AGUILAR, Ruth, JORDÁN GARCÍA, Iolanda, MONCUNILL PIÑAS, Gemma. Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts. _Frontiers in Immunology_. 2022. Vol. 13, núm. 751705. [consulta: 24 de gener de 2026]. ISSN: 1664-3224. [Disponible a: https://hdl.handle.net/2445/186809]

Exportar metadades

JSON - METS

Compartir registre